Leucocyte common antigen expression on T cells in normal and inflamed human gut

Area of Science:

• Immunology
• Gastroenterology
• Cell Biology

Background:

• The leucocyte common antigen (LCA) family includes glycoproteins crucial for immune cell function.
• Intestinal mucosal lymphocytes play a key role in maintaining gut homeostasis and responding to inflammation.
• Altered immune cell marker expression is implicated in inflammatory bowel diseases like coeliac and Crohn's disease.

Purpose of the Study:

• To investigate the expression of the p220 glycoprotein (a component of LCA) on intestinal T cells.
• To determine if p220 expression changes in inflammatory conditions such as coeliac and Crohn's disease.
• To explore the relationship between p220 expression and T-cell activation in the gut.

Main Methods:

• Utilized CD45R monoclonal antibody WR16 to detect the p220 glycoprotein on intestinal mucosal lymphocytes.
• Employed UCHL1 monoclonal antibody to identify another LCA family member (180,000 MW) on T cells and macrophages.
• Analyzed the distribution and proportion of WR16+ and UCHL1+ CD3+ T cells in normal intestinal tissue and in inflammatory infiltrates of coeliac and Crohn's disease.

Main Results:

• In normal intestine, a subset of CD3+ T cells (WR16+) was found in the lamina propria, primarily in the mid-villus and crypt regions.
• The CD3+, WR16+ T-cell population was significantly reduced in the inflammatory infiltrates of coeliac and Crohn's disease.
• In contrast, UCHL1+ T cells remained abundant in both normal and inflamed intestinal tissues, including coeliac and Crohn's disease.

Conclusions:

• The marked reduction of WR16+ (p220+) T cells in coeliac and Crohn's disease suggests a loss of the p220 molecule.
• These findings support the hypothesis that p220 molecule loss is associated with T-cell activation during intestinal inflammation.
• The differential expression of p220 and UCHL1 highlights distinct T-cell populations and activation states in gut inflammation.